Cambrex to Present at the 2017 RBC Capital Markets Global Healthcare Conference
EAST RUTHERFORD, N.J., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Steven Klosk, President and Chief …